Acta Pharmaceutica

Acta Pharmaceutica 由 Sciendo, a De Gruyter company 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Drug Solubulity and Delivery Systems、Advanced Drug Delivery Systems、Analytical Methods in Pharmaceuticals 等主题的论文，这 3 个主题约占 34%，主导子领域为 Pharmaceutical Science、Organic Chemistry。（根据 OpenAlex 主题统计与中科院分区数据生成）

Acta Pharmaceutica (AP) is a quarterly journal dealing with all branches of pharmaceutical and related sciences, respecting openness, authenticity, ethics and transparency. It is an international, scientific, multidisciplinary journal, which brings articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of original research papers (articles), preliminary and short communications, and reviews (systematic/critical, mini reviews, meta-analysis and bibliometric-analysis reviews). Book reviews are published also.Acta Pharmaceutica is a single-blind, peer-reviewed journal (at least two independent referees after the desk pre-review). It is also an open access journal (“gold” OA) with “early bird” sections on editorial manager platform. To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.All submitted manuscripts should conform to generally accepted usage in composition of research papers. For technical requirements author should consult Information for authors and the recent issues.Submission of materials generated by AI is discouraged. Neither is allowed to submit paper-mills-produced materials. Otherwise retraction policy might be activated. AI must not be used during reviewing process either.The use of official institutional e-mail address during paper submittance and afterwards is strongly recommended. Otherwise, Authentication letter issued and signed by the affiliating institution, during submission process (template provided at the end of Instructions for Authors) is expected.Numerous topics are covered by Acta Pharmaceutica from analytics of drugs, biochemistry (pharmaceutical/clinical), biophysics, bioinformatics, cell biology, clinical pharmacy, cosmetology, drug design/delivery/disposition and stability, drug metabolism, genetics, medicine (including diagnostics and therapy), molecular modelling/docking studies, nanomedicine, networking and computational drug designing, network pharmacology, peptide and

摘自期刊官网 Aims & Scope

研究方向（LetPub）：PHARMACOLOGY & PHARMACY

编委会国家分布：未见中国大陆编委；主要国家 克罗地亚 13、斯洛文尼亚 5（共 18 位编委标注了国家） 编委会 ↗出版商官网 · 2026-09-29

中科院期刊分区表

数据库收录

SCIEScopusDOAJLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

1.77LetPub · 2026-09-13

影响因子（出版商公布）

18出版商官网 · 2026-09-29

CiteScore 2026-06

3.2LetPub · 2026-09-13

CiteScore（出版商公布）

32出版商官网 · 2026-09-29

SJR 2026-06

0.46LetPub · 2026-09-13

SNIP 2026-06

0.53LetPub · 2026-09-13

h-index

49LetPub · 2026-09-13

h-index

63OpenAlex · 2026-10-01

i10-index

479OpenAlex · 2026-10-01

两年平均被引

2.5OpenAlex · 2026-10-01

自引率

0%LetPub · 2026-09-13

Gold OA 文章占比

100%LetPub · 2026-09-13

发文规模

年文章数

41LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

平均审稿速度（社区反馈）

>12周，或约稿LetPub · 2026-09-13

平均录用比例（社区反馈）

容易LetPub · 2026-09-13

投稿到发表（期刊自报）

约 20 周DOAJ · 2026-10-11

评审方式

单盲同行评审DOAJ

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

• APC 费用说明 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Sciendo, a De Gruyter company

出版国家或地区

CROATIA

出版语言

English

出版周期

Quarterly

创刊年份

1951

ISSN

1330-0075

电子版 ISSN

1846-9558

官方链接

• 期刊主页 ↗DOAJ
• 作者指南 ↗DOAJ
• Aims & Scope ↗DOAJ
• APC 费用说明 ↗DOAJ
• 开放获取声明 ↗DOAJ
• 许可与版权 ↗DOAJ
• 评审流程 ↗DOAJ
• 编委会 ↗DOAJ
• 查重政策 ↗DOAJ